Your session is about to expire
← Back to Search
Transcranial Magnetic Stimulation for Post-Traumatic Stress Disorder
Study Summary
This trial will test if a magnetic field can help reduce PTSD symptoms.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with PTSD by a standardized test.My health condition is currently stable.I have a history of seizures.
- Drug Has Already Been Approved - The FDA has already approved this drug, and is just seeking more data.
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Has this therapeutic intervention received the seal of approval from the Food and Drug Administration?
"Having undergone Phase 4 clinical trials, this treatment has been certified safe and thus scored a 3 on our team's risk rating scale."
Are there any enrolment opportunities for individuals in this clinical trial?
"Confirmation from clinicaltrials.gov confirms that this particular trial is no longer seeking applicants, with the last edit made on October 28th 2005. Despite this, there are 1,236 other medical trials still actively recruiting patients at present moment in time."
Is this trial open to geriatric patients?
"This trial seeks participants between the age of majority and 75 years old."
Who is eligible to participate in this investigation?
"In order to meet the requirements of this research initiative, participants must demonstrate symptoms of moral injury and be between 18-75 years old. At present, approximately 40 applicants will be accepted into the trial."
Share this study with friends
Copy Link
Messenger